博九娱乐网

AtriCure, Inc. provides innovative technologies for the treatment of Afib and related conditions. Afib affects more than 33 million people worldwide. Electrophysiologists and cardiothoracic surgeons around the globe use AtriCure technologies for the treatment of Afib and reduction of Afib related complications. AtriCure鈥檚 Isolator庐 Synergy鈩� Ablation System is the first and only medical…More device to receive FDA approval for the treatment of persistent Afib. AtriCure鈥檚 AtriClip Left Atrial Appendage Exclusion System products are the most widely sold LAA management devices worldwide.